Cumulative risk of a false‐positive screening result: A retrospective cohort study using empirical data from 10 biennial screening rounds in BreastScreen Norway

Background False‐positive screening results are an inevitable and commonly recognized disadvantage of mammographic screening. This study estimated the cumulative probability of experiencing a first false‐positive screening result in women attending 10 biennial screening rounds in BreastScreen Norway, which targets women aged 50 to 69 years. Methods This retrospective cohort study analyzed screening outcomes from 421,545 women who underwent 1,894,523 screening examinations during 1995‐2019. Empirical data were used to calculate the cumulative risk of experiencing a first false‐positive screening result and a first false‐positive screening result that involved an invasive procedure over 10 screening rounds. Logistic regression was used to evaluate the effect of adjusting for irregular attendance, age at screening, and number of screens attended. Results The cumulative risk of experiencing a first false‐positive screening result was 18.04% (95% confidence interval [CI], 18.00%‐18.07%). It was 5.01% (95% CI, 5.01%‐5.02%) for experiencing a false‐positive screening result that involved an invasive procedure. Adjusting for irregular attendance or age at screening did not appreciably affect these estimates. After adjustments for the number of screens attended, the cumulative risk of a first false‐positive screening result was 18.28% (95% CI, 18.24%‐18.32%), and the risk of a false‐positive screening result including an invasive procedure was 5.11% (95% CI, 5.11%‐5.22%). This suggested that there was minimal bias from dependent censoring. Conclusions Nearly 1 in 5 women will experience a false‐positive screening result if they attend 10 biennial screening rounds in BreastScreen Norway. One in 20 will experience a false‐positive screening result with an invasive procedure. Lay Summary A false‐positive screening result occurs when a woman attending mammographic screening is called back for further assessment because of suspicious findings, but the assessment does not detect breast cancer. Further assessment includes additional imaging. Usually, it involves ultrasound, and sometimes, it involves a biopsy. This study has evaluated the chance of experiencing a false‐positive screening result among women attending 10 screening examinations over 20 years in BreastScreen Norway. Nearly 1 in 5 women will experience a false‐positive screening result over 10 screening rounds. One in 20 women will experience a false‐positive screening result involving a biopsy. Using data fro